These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19803699)

  • 21. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.
    van der Eerden MM; Vlaspolder F; de Graaff CS; Groot T; Bronsveld W; Jansen HM; Boersma WG
    Thorax; 2005 Aug; 60(8):672-8. PubMed ID: 16061709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community-acquired pneumonia.
    Lynch JP; Martinez FJ
    Curr Opin Pulm Med; 1998 May; 4(3):162-72. PubMed ID: 9675519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.
    Shorr AF; Khashab MM; Xiang JX; Tennenberg AM; Kahn JB
    Respir Med; 2006 Dec; 100(12):2129-36. PubMed ID: 16730170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.
    Dunbar LM; Khashab MM; Kahn JB; Zadeikis N; Xiang JX; Tennenberg AM
    Curr Med Res Opin; 2004 Apr; 20(4):555-63. PubMed ID: 15119993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tigecycline for the treatment of Acinetobacter infections: a case series.
    Gallagher JC; Rouse HM
    Ann Pharmacother; 2008 Sep; 42(9):1188-94. PubMed ID: 18614749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.
    Freire AT; Melnyk V; Kim MJ; Datsenko O; Dzyublik O; Glumcher F; Chuang YC; Maroko RT; Dukart G; Cooper CA; Korth-Bradley JM; Dartois N; Gandjini H;
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):140-51. PubMed ID: 20846586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tigecycline: a novel broad-spectrum antimicrobial.
    Slover CM; Rodvold KA; Danziger LH
    Ann Pharmacother; 2007 Jun; 41(6):965-72. PubMed ID: 17519296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of community acquired pneumonia].
    Böszörményi Nagy G
    Orv Hetil; 2004 May; 145(22):1189-92. PubMed ID: 15279407
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcus aureus recovered from nosocomial and community-acquired infections.
    Fritsche TR; Jones RN
    Int J Antimicrob Agents; 2004 Dec; 24(6):567-71. PubMed ID: 15555879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
    Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience.
    Dartois N; Castaing N; Gandjini H; Cooper A;
    J Chemother; 2008 Oct; 20 Suppl 1():28-35. PubMed ID: 19036672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of tigecycline against Streptococcus pneumoniae, an important causative pathogen of community-acquired pneumonia (CAP).
    Hawser SP
    J Infect; 2010 Apr; 60(4):306-8. PubMed ID: 20144899
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections.
    Bradford PA; Weaver-Sands DT; Petersen PJ
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S315-32. PubMed ID: 16080070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.
    Carratalá J; Martín-Herrero JE; Mykietiuk A; García-Rey C
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():2-11. PubMed ID: 16669924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK; Triller DM; Yong CS; Lodise TP
    Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
    Bouchillon SK; Hoban DJ; Johnson BM; Johnson JL; Hsiung A; Dowzicky MJ;
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM; Davis NB; Wu SC; Kahn J
    Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections.
    Grolman DC
    Int J Infect Dis; 2007 May; 11 Suppl 1():S7-15. PubMed ID: 17603950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.